Zantac 75 Ad Comparison to Prilosec OTC Needs Revision, NAD Concludes
This article was originally published in The Tan Sheet
Executive Summary
Ad claims for Pfizer's Zantac 75 that compare the H2 antagonist to Procter & Gamble's Prilosec OTC should be modified so consumers understand the heartburn remedies have different indications, the National Advertising Division of the Council for Better Business Bureaus concludes following a recent inquiry